Gene expression profiling identifies a prognostically favorable subgroup in AML independent of cytogenetic stratification.

被引：0
|
作者：
Schoch, C [1 ]
Kern, W [1 ]
Kohlmann, A [1 ]
Hiddemann, W [1 ]
Merk, S [1 ]
Schnittger, S [1 ]
Haferlach, T [1 ]
机构：
[1] LMU Grosshadern, Dept Internal Med 2, Lab Leukemia Diagnost, Munich, Germany
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.569.569
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
569
引用
收藏
页码：164A / 165A
页数：2
相关论文
共 50 条
  • [1] Gene expression profiling of pediatric acute lymphoblastic leukemia reveals unique subgroups independent of current genetic risk stratification.
    Viswanatha, D
    Mosquera-Caro, M
    Potter, J
    Wilson, C
    Ar, K
    Xu, YX
    Harvey, R
    Hellman, P
    Verhoff, B
    Davidson, G
    Shuster, J
    Carroll, A
    Camitta, B
    Atlas, S
    Willman, C
    BLOOD, 2002, 100 (11) : 753A - 753A
  • [2] Expression profiling and mutational analysis identifies a new subgroup of normal karyotype AML.
    Debernardi, S
    Smith, M
    Lillington, DM
    Chaplin, T
    Rohatiner, A
    Lister, A
    Young, BD
    BLOOD, 2003, 102 (11) : 364A - 364A
  • [3] Molecular Stratification of Elderly Patients with Glioblastoma (GBM) Identifies a Subgroup with a Favorable Prognosis
    Choe, K. S.
    Park, S.
    Hwang, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S39 - S39
  • [4] An RCOR1 loss-associated gene expression signature identifies a prognostically significant DLBCL subgroup
    Chan, Fong Chun
    Telenius, Adele
    Healy, Shannon
    Ben-Neriah, Susana
    Mottok, Anja
    Lim, Raymond
    Drake, Marie
    Hu, Sandy
    Ding, Jiarui
    Ha, Gavin
    Scott, David W.
    Kridel, Robert
    Bashashati, Ali
    Rogic, Sanja
    Johnson, Nathalie
    Morin, Ryan D.
    Rimsza, Lisa M.
    Sehn, Laurie
    Connors, Joseph M.
    Marra, Marco A.
    Gascoyne, Randy D.
    Shah, Sohrab P.
    Steidl, Christian
    BLOOD, 2015, 125 (06) : 959 - 966
  • [5] FAVORABLE IMPACT ON MAINLY INTERMEDIATE CYTOGENETIC RISK AML CAN BE PREDICTED BY GENE EXPRESSION PROFILING-RESULTS OF A PHASE I/II TRIAL OF BELINOSTAT IN COMBINATION WITH IDARUBICIN IN AML
    Bullinger, L.
    Knudsen, S.
    Dombret, H.
    Dennis, M.
    Neubauer, A.
    Pfreundschuh, M.
    Rossi, J.
    Knoblauch, P.
    Tjornelund, J.
    Schlenk, R. F.
    ANNALS OF ONCOLOGY, 2012, 23 : 349 - 350
  • [6] Proteomic Profiling of Smad Proteins Expression in AML: Pan Expression with High Phosphorylation Is Prognostically Adverse
    Chae, Young Kwang
    Zhang, Nianxiang
    Qiu, Yihua
    Kadia, Tapan M.
    Ferrajoli, Alessandra
    Coombes, Kevin R.
    Kornblau, Steven M.
    BLOOD, 2012, 120 (21)
  • [7] Coinhibitory Expression Profiling of AML Blasts Identifies HVEM as Prognostic Marker in AML
    Lichtenegger, Felix S.
    Kondla, Isabell
    Krempasky, Michael
    Weber, Anna L.
    Schneider, Stephanie
    Spiekermann, Karsten
    Braess, Jan
    Hiddemann, Wolfgang
    Subklewe, Marion
    BLOOD, 2013, 122 (21)
  • [8] Low MDR1 and BAALC expression identifies a new subgroup of intermediate cytogenetic risk acute myeloid leukemia with a favorable outcome
    Guo, Xutao
    Shi, Pengcheng
    Chen, Feili
    Zha, Jie
    Liu, Bingshan
    Li, Rongwei
    Dong, Huijuan
    Zheng, Haiqing
    Xu, Bing
    BLOOD CELLS MOLECULES AND DISEASES, 2014, 53 (03) : 144 - 148
  • [9] Gene expression profiling and subgroup identification of oligodendrogliomas
    Hervé Huang
    Yoshikazu Okamoto
    Hideaki Yokoo
    Frank L Heppner
    Anne Vital
    Michelle Fevre-Montange
    Anne Jouvet
    Yasuhiro Yonekawa
    Emmanuel N Lazaridis
    Paul Kleihues
    Hiroko Ohgaki
    Oncogene, 2004, 23 : 6012 - 6022
  • [10] Gene expression profiling and subgroup identification of oligodendrogliomas
    Huang, H
    Okamoto, Y
    Yokoo, H
    Heppner, FL
    Vital, A
    Fevre-Montange, M
    Jouvet, A
    Yonekawa, Y
    Lazaridis, EN
    Kleihues, P
    Ohgaki, H
    ONCOGENE, 2004, 23 (35) : 6012 - 6022
12345